Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucosetolerance (ACE): a randomised, double-blind, placebo-controlled trial - Holman, R R; Coleman, R L; Chan, JC N (Lancet Diabetes Endocrinol, 2017)
et al.